Psychedelics UC San Diego receives US$1.5M for cognitive research on DMT Fund supporting the institution's Psychedelics and Health Research Initiative was provided by philanthropist Eugene Jhong Rowan DunneJuly 11, 2023
News PharmAla Biotech secures first purchase order for GMP LaNeo MDMA in Australia Patients in Australia can use psilocybin and MDMA as of July 1 Natalia Buendia CalvilloJuly 5, 2023
Psychedelics FDA publishes first draft guidance document for psychedelics research It aims to highlight relevant considerations for researchers investigating the therapeutic value of psychedelics Rowan DunneJune 23, 2023
Psychedelics Optimi Health to supply MDMA for new psychedelic therapy program at Numinus clinics The experiential training will only be available through Numinus and will utilize the protocol of MAPS Rowan DunneJune 15, 2023
News Mind Medicine Australia to supply medical psilocybin and MDMA for clinical trials at no cost It is particularly interested in supporting research that optimizes treatment results and extends the application of psychedelic-assisted therapies Natalia Buendia CalvilloMay 18, 2023
News Optimi Health completes harvesting psilocybin mushrooms for Australia-bound medical extract Australia will allow psychiatrists to prescribe psilocybin and MDMA for certain conditions as of July 1 Natalia Buendia CalvilloMay 17, 2023
Psychedelics PharmAla Biotech first to get Special Access Program authorization for its MDMA Health Canada granted PharmAla approval to provide its LaNeo product to a physician that will facilitate MDMA-assisted therapy Rowan DunneMay 16, 2023
Psychedelics Optimi Health enters $1.2M psilocybin distribution agreement The mushroom cultivator will be supplying a private client for clinical research purposes Rowan DunneMay 4, 2023
News PharmAla Biotech and Vitura Health form joint psychedelics venture in Australia To help the new venture get started, Vitura has agreed to provide up to $2.2 million in loans Natalia Buendia CalvilloMay 2, 2023
Psychedelics Incannex orders psilocybin and MDMA from PharmAla Biotech Incannex plans to open a series of psychedelics clinics in Australia and use PharmAla's products Rowan DunneApril 25, 2023